InsidersTradesSigma
Track the HLS share price and the full management transaction log of the company, a listed issuer based in Australia. Shares are listed on AU AU, under the supervision of ASX. Operating in the Health Care sector, HLS has logged 6 public disclosures. Market capitalisation: €283.2m. The latest transaction was filed on 9 July 2026 (Cease Substantial Holding). Among the most active insiders: its controlled bodies corporate listed in Annexure A. All data is free.
Analysts rate HLS Hold (neutral), based on 10 analysts. Average price target: A$0.51.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
HLS is a company operating in the healthcare and pharmaceutical sector, listed on the XASX market. It focuses on the development and commercialization of innovative solutions for the medical field.